ConversationGood morning, and welcome to TD Cowen's 46th Annual Healthcare Conference. I'm Phil Nadeau, one of the Biotech analysts here at Cowen, and it's my pleasure to moderate a fireside chat with Chris Viehbacher, CEO of Biogen. Chris, could you give us your vision for Biogen over the next 5 years? How is it going to create shareholder value?Christopher ViehbacherPresident, CEO & Director So good morning, everybody. And Phil, I just want to thank you and Cowen for always holding the conference here in ...